Juanjuan Yu

Suzhou, 215003, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

An Integrated Transcriptional and Post-Transcriptional Regulatory Circuit Orchestrated by NUDT21 Maintains the Proliferation and Survival of Neuroblastoma.

An Integrated Transcriptional and Post-Transcriptional Regulatory Circuit Orchestrated by NUDT21 Maintains the Proliferation and Survival of Neuroblastoma.

Journal: Neuro-oncology
Published: December 26, 2025

NUDT21 Drives T-Cell Acute Lymphoblastic Leukemia Through Dual Regulation of Alternative Polyadenylation and Transcriptional Activation.

NUDT21 Drives T-Cell Acute Lymphoblastic Leukemia Through Dual Regulation of Alternative Polyadenylation and Transcriptional Activation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 17, 2025

NeuroD1-USP1-MYCN axis drives tumor progression in neuroblastoma.

NeuroD1-USP1-MYCN axis drives tumor progression in neuroblastoma.

Journal: Journal of translational medicine
Published: October 07, 2025

USP20, a Super-enhancer Regulated Gene, Promotes Acute Myeloid Leukemia Progression through CTNNB1 Deubiquitination.

USP20, a Super-enhancer Regulated Gene, Promotes Acute Myeloid Leukemia Progression through CTNNB1 Deubiquitination.

Journal: International journal of biological sciences
Published: August 01, 2025

Targeting super-enhancer-driven MAB21L2 suppresses neuroblastoma growth and migration.

Targeting super-enhancer-driven MAB21L2 suppresses neuroblastoma growth and migration.

Journal: Experimental cell research
Published: July 08, 2025

KIF11 promotes AML progression, and its inhibition by SB-743921 suppresses disease advancement through mitotic G2/M phase arrest.

KIF11 promotes AML progression, and its inhibition by SB-743921 suppresses disease advancement through mitotic G2/M phase arrest.

Journal: Cellular signalling
Published: June 03, 2025

Super-enhancer-driven ELOVL5 promotes T-ALL progression through the MYC-SERBP1 pathway.

Super-enhancer-driven ELOVL5 promotes T-ALL progression through the MYC-SERBP1 pathway.

Journal: Genomics
Published: June 03, 2025

The BET degrader BETd-246 demonstrated significant anti-tumor efficacy in T-cell acute lymphoblastic leukemia by inhibiting TRAT1.

The BET degrader BETd-246 demonstrated significant anti-tumor efficacy in T-cell acute lymphoblastic leukemia by inhibiting TRAT1.

Journal: Experimental cell research
Published: May 25, 2025

NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia.

NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia.

Journal: Cancer biology & therapy
Published: January 12, 2025

The super-enhancer regulatory gene SH2D1A promotes the progression of T cell acute lymphoblastic leukemia by activating CHI3L2.

The super-enhancer regulatory gene SH2D1A promotes the progression of T cell acute lymphoblastic leukemia by activating CHI3L2.

Journal: Cellular signalling
Published: January 06, 2025

Core transcriptional regulatory circuit-regulated IGF2BP3 stabilizes E2F2 mRNA via m6A modification in neuroblastoma.

Core transcriptional regulatory circuit-regulated IGF2BP3 stabilizes E2F2 mRNA via m6A modification in neuroblastoma.

Journal: Carcinogenesis
Published: December 31, 2024

USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination.

USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination.

Journal: Acta pharmaceutica Sinica. B
Published: November 12, 2024
Showing 1-12 of 31

Last Updated: 09/26/2026